WHO ICTRP trial
Addressing smoking in patients following discharge from Intensive Care
ACTRN12622001205729 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12622001205729 |
|---|---|
| Public title | Addressing smoking in patients following discharge from Intensive Care |
| Scientific title | A brief counselling intervention addressing smoking cessation: a randomized controlled trial in Intensive Care patients |
| Primary sponsor | Sir Charles Gairdner and Osborne Park Hospital Group |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Australia |
| Conditions | Smoking; Smoking;Public Health - Health promotion/education;Mental Health - Addiction |
| Interventions | Nicotine replacement therapy (patch 21mg) replaced daily, until discharge from hospital. Medication adherence will be monitored using hospital medication chart. + Brief Intervention - A formal brief counselling intervention consisting of a… |
| Registration date | Aug 9, 2022 |
| Target size | 100 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: